Avacta Group (AVCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Jul 2008 07:00 AM
PRN
Customer Agreement
14 Apr 2008 07:00 AM
PRN
Half-yearly Report
04 Apr 2008 05:20 PM
RNS
Director/PDMR Shareholding
31 Mar 2008 07:00 AM
RNS
Total Voting Rights
10 Mar 2008 03:12 PM
RNS
Issue of Equity
31 Jan 2008 11:36 AM
RNS
Total Voting Rights
07 Jan 2008 10:50 AM
PRN
Re Agreement
02 Jan 2008 05:14 PM
PRN
Issue of Equity
31 Dec 2007 07:00 AM
PRN
Total Voting Rights
14 Dec 2007 03:30 PM
PRN
Acquisition(s)
14 Dec 2007 03:05 PM
PRN
AGM Statement
21 Nov 2007 07:01 AM
RNS
Notice of AGM
14 Nov 2007 09:08 AM
PRN
Acquisition
09 Nov 2007 04:59 PM
PRN
Directorate Appointment
25 Sep 2007 07:00 AM
PRN
Final Results
03 Sep 2007 07:00 AM
PRN
Re Agreement
14 Aug 2007 03:59 PM
RNS
AIM Rule 26 Information
13 Aug 2007 07:00 AM
PRN
Re Agreement
31 Jul 2007 03:37 PM
RNS
Total Voting Rights
26 Jul 2007 09:53 AM
PRN
Issue of Equity
05 Jul 2007 07:00 AM
PRN
Re Agreement
25 Apr 2007 04:29 PM
PRN
Holding(s) in Company
10 Apr 2007 11:59 AM
PRN
Director Shareholding
05 Apr 2007 12:13 PM
PRN
Total Voting Rights
04 Apr 2007 07:00 AM
PRN
Placing and Appointment of joint broker
04 Apr 2007 07:00 AM
PRN
Product Launch
30 Jan 2007 01:51 PM
PRN
Interim Results
21 Dec 2006 08:44 AM
PRN
Total Voting Rights
29 Nov 2006 07:00 AM
PRN
Re Agreement
20 Oct 2006 03:40 PM
RNS
Change of accounting ref date
11 Oct 2006 11:12 AM
RNS
Annual Report and Accounts
19 Sep 2006 07:00 AM
PRN
Re Agreement
24 Aug 2006 07:00 AM
PRN
Collaboration Agreement
09 Aug 2006 08:03 AM
PRN
Supplementary consideration shares
08 Aug 2006 08:00 AM
PRN
First Day of Dealings
07 Aug 2006 12:58 PM
RNS
Result of EGM
14 Jul 2006 02:20 PM
RNS
Final Results
14 Jul 2006 12:00 PM
RNS
Propsd Aqstn & notice of EGM
13 Jul 2006 09:30 AM
RNS
Stmnt re Proposed Transaction
07 Jul 2006 04:07 PM
RNS
Directorate Change
05 May 2006 11:24 AM
RNS
Result of EGM
19 Apr 2006 03:13 PM
RNS
Further re Issue of Equity
19 Apr 2006 08:08 AM
RNS
Holding(s) in Company
13 Apr 2006 05:28 PM
RNS
Holding(s) in Company
12 Apr 2006 07:44 AM
RNS
Issue of Equity
09 Mar 2006 02:19 PM
RNS
Holding(s) in Company
26 Jan 2006 08:23 AM
RNS
Interim Results
24 Aug 2005 07:00 AM
RNS
Final Results
25 Jul 2005 07:57 AM
RNS
Board change & trading update
17 Jun 2005 11:09 AM
RNS
Business Strategy

Avacta Group plc is a United Kingdom-based life sciences company focused on improving healthcare outcomes through targeted cancer treatments and diagnostics. The Company has two segments: Therapeutics and Diagnostics. The Therapeutics segment is a clinical stage oncology biotech division harnessing therapeutic platforms to develop novel, highly targeted cancer drugs. The Diagnostics segment is focused on supporting healthcare professionals and broadening access to diagnostics.

It has two platforms: preICISION and Affimer. The Company's preICISION platform is a highly specific substrate for fibroblast activation protein (FAP) which is upregulated in most solid tumors compared with healthy tissues. The preICISION platform harnesses this tumor specific protease to activate preICISION peptide drug conjugates and preICISION antibody/Affimer drug conjugates in the tumor microenvironment. Its lead preICISION program AVA6000, a peptide drug conjugate form of doxorubicin, is in Phase 1 studies.

Avacta Group share price launched at 5,448p in 2003. 

UK 100

Latest directors dealings